Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter H Scanlon

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Ophthalmic Research|May 28, 2019
Update on Screening for Sight-Threatening Diabetic RetinopathyPeter H Scanlon
Expert Review of Endocrinology & Metabolism|June 22, 2022
Improving the screening of risk factors in diabetic retinopathyPeter H Scanlon
Acta Diabetologica|February 23, 2017
The English National Screening Programme for diabetic retinopathy 2003-2016Peter H Scanlon
Acta Diabetologica|April 8, 2021
The contribution of the English NHS Diabetic Eye Screening Programme to reductions in diabetes-related blindness, comparisons within Europe, and future challengesPeter H Scanlon
Current Diabetes Reports|September 7, 2017
Screening Intervals for Diabetic Retinopathy and Implications for CarePeter H Scanlon
Middle East African Journal of Ophthalmology|December 17, 2013
Epidemiological issues in diabetic retinopathyPeter H Scanlon, Stephen J Aldington, Irene M Stratton
Eye (London, England)|July 15, 2025
A thematic analysis of patients' experiences of receiving treatment for Neovascular age-related macular degeneration (nAMD)Julie Hapeshi, Samantha Hughes, Martin McKibbin, et al.
Eye (London, England)|March 14, 2023
Disengagement and loss to follow-up in intravitreal injection clinics for neovascular age-related macular degenerationRebecca Jones, Irene M Stratton, Peter H Scanlon, et al.
Acta Ophthalmologica|April 5, 2013
The influence of background diabetic retinopathy in the second eye on rates of progression of diabetic retinopathy between 2005 and 2010Peter H Scanlon, Irene M Stratton, Mark Histed, et al.
Eye (London, England)|December 4, 2018
Cost-effectiveness of digital surveillance clinics with optical coherence tomography versus hospital eye service follow-up for patients with screen-positive maculopathyJose Leal, Ramon Luengo-Fernandez, Irene M Stratton, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Ophthalmic Research|May 28, 2019
Update on Screening for Sight-Threatening Diabetic RetinopathyPeter H Scanlon
Expert Review of Endocrinology & Metabolism|June 22, 2022
Improving the screening of risk factors in diabetic retinopathyPeter H Scanlon
Acta Diabetologica|February 23, 2017
The English National Screening Programme for diabetic retinopathy 2003-2016Peter H Scanlon
Acta Diabetologica|April 8, 2021
The contribution of the English NHS Diabetic Eye Screening Programme to reductions in diabetes-related blindness, comparisons within Europe, and future challengesPeter H Scanlon
Current Diabetes Reports|September 7, 2017
Screening Intervals for Diabetic Retinopathy and Implications for CarePeter H Scanlon
Middle East African Journal of Ophthalmology|December 17, 2013
Epidemiological issues in diabetic retinopathyPeter H Scanlon, Stephen J Aldington, Irene M Stratton
Eye (London, England)|July 15, 2025
A thematic analysis of patients' experiences of receiving treatment for Neovascular age-related macular degeneration (nAMD)Julie Hapeshi, Samantha Hughes, Martin McKibbin, et al.
Eye (London, England)|March 14, 2023
Disengagement and loss to follow-up in intravitreal injection clinics for neovascular age-related macular degenerationRebecca Jones, Irene M Stratton, Peter H Scanlon, et al.
Acta Ophthalmologica|April 5, 2013
The influence of background diabetic retinopathy in the second eye on rates of progression of diabetic retinopathy between 2005 and 2010Peter H Scanlon, Irene M Stratton, Mark Histed, et al.
Eye (London, England)|December 4, 2018
Cost-effectiveness of digital surveillance clinics with optical coherence tomography versus hospital eye service follow-up for patients with screen-positive maculopathyJose Leal, Ramon Luengo-Fernandez, Irene M Stratton, et al.
Pageof 3